Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

The Lead

Pharmaceutical Trade Association: Greek Medicine Supply May Be At Risk

June 30, 2015 | by Ryan Bushey, Associate Editor | Articles | Comments

The organization is calling for the European Union to take emergency action. Read more...

TOPICS:
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Novartis to Try Novel Pricing Strategy for Heart Failure Drug

June 30, 2015 4:39 pm | by Ryan Bushey, Associate Editor | Articles | Comments

The company is treading in establishing the exact cost per pill. Read more...

TOPICS:

BiondVax Announces Positive Preliminary Phase 2 Results for Universal Flu Vaccine

June 30, 2015 4:28 pm | News | Comments

These results support BiondVax’s claim that M-001 provides a broaden and improved coverage against multiple influenza type A and B virus strains. Read more...

TOPICS:

Research Reveals New Insights into Key Antibiotic Target in Fight Against TB

June 30, 2015 4:19 pm | by University of Sussex | News | Comments

While TB is curable, antibiotic resistance is on the rise and so a major challenge for scientists is to continually develop new drugs to treat the disease. Read more...

TOPICS:
Advertisement

Liberia Quarantines an Area Where New Ebola Case Appeared

June 30, 2015 4:11 pm | by Jonathan Paye-Layleh, Associated Press | News | Comments

The World Health Organization declared Liberia Ebola-free on May 9, after it went 42 days without a new case. Read more...

TOPICS:

The Leukemia & Lymphoma Society Accelerates Payment Linked to Phase 3 AML Study

June 30, 2015 12:24 pm | by The Leukemia & Lymphoma Society | News | Comments

Celator Pharmaceuticals, Inc. today announced that The Leukemia & Lymphoma Society (LLS) is accelerating a portion of the final payment linked to the Phase 3 study of CPX-351 (cytarabine:daunorubicin) liposome injection, Celator's lead product candidate, for the treatment of patients with high-risk (secondary) acute myeloid leukemia (AML). Read more...

TOPICS:

National Study Finds Life-Threatening Barriers in Access to Breakthrough Drugs

June 30, 2015 12:16 pm | by Lifespan | News | Comments

Most states violate federal Medicaid law because they deny coverage for sofosbuvir, a new and highly effective treatment to cure hepatitis C, according to Lynn E. Taylor, M.D., director of The Miriam Hospital's HIV/Viral Hepatitis Coinfection Program.  Read more...

TOPICS:

Treatment With PI3K Inhibitors May Cause Cancers to Become Aggressive, Metastatic

June 30, 2015 11:43 am | by The Wistar Institute | News | Comments

The enzyme phosphatidylinositol-3 kinase (PI3K) appears to be exploited in almost every type of human cancer, making it the focus of considerable interest as a therapeutic target, with many PI3K-inhibiting drugs currently in various stages of clinical development.  Read more...

TOPICS:

Regeneron's Retinal Vein Occlusion Treatment Receives Approval in Japan

June 30, 2015 8:39 am | News | Comments

This new indication includes macular edema secondary to branch retinal vein occlusion in addition to the previously-approved indication of macular edema secondary to central retinal vein occlusion. Read more...

TOPICS:
Advertisement

Global Biosimilars Market Value Could Hit $55B by 2020

June 30, 2015 8:28 am | by Sumith Ladda, Analyst, GBI Research | Articles | Comments

The 30 percent to 50 percent reduction in biosimilar prices compared with branded biologics could lead to considerable savings in healthcare expenditure. Read more...

TOPICS:

CHMP Recommends EU Approval for Novartis' Multiple Myeloma Treatment

June 30, 2015 8:18 am | News | Comments

Multiple myeloma is a cancer of the plasma cells, a type of white blood cell present in the bone marrow, and affects approximately 84,000 people in Europe. Read more...

TOPICS:

New Study Verifies Accuracy of Rapid Ebola Test

June 30, 2015 8:18 am | by Tulane University | News | Comments

The study results confirm that the test can be used in the field and deliver a high level of accuracy. Read more...

TOPICS:

Multi-Million-Dollar Deal Brings UQ Pain Drug Closer to Reality

June 30, 2015 8:18 am | by University of Queensland | News | Comments

A chronic pain treatment discovered at The University of Queensland is a step closer to clinical use. Read more...

TOPICS:

Conn. Nurse Pleads Guilty to Prescribing Pain Meds for Drug-Company Kickbacks

June 29, 2015 11:56 am | by Seth Augenstein, Digital Reporter | News | Comments

A nurse admitted in federal court to prescribing pain medications in exchange for kickbacks from a drug company, according to authorities. Read more...

TOPICS:

Lilly, Immunocore: Immunotherapy-based Clinical Trial Collaboration in Melanoma

June 29, 2015 9:48 am | News | Comments

Eli Lilly and Company and Immunocore Limited today announced that they have entered into an immunotherapy-based clinical trial collaboration to explore the utility of Immunocore's lead T cell receptor-based investigational therapeutic, IMCgp100, in combination with Lilly's galunisertib (LY2157299) and merestinib (LY2801653) for the treatment of melanoma. Read more...

TOPICS:

Scientists Look Into Why Most Alzheimer's Patients Are Women

June 29, 2015 9:42 am | by Lauren Neergaard, AP Medical writer - Associated Press | News | Comments

Nearly two-thirds of Americans with Alzheimer's disease are women, and now some scientists are questioning the long-held assumption that it's just because they tend to live longer than men. Read more..

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading